Penn State Cancer Institute led a study of over 12 million cancer patients between 2005-2015 and found that although cancer-based clinical trials may increase life expectancy, patient participation in that clinical research is extremely low. Moreover, to date,...
University of Texas at Austin-led research discovers that 73% of head and neck cancers are related to human papillomavirus (HPV) which is vaccine preventable. Human Papillomavirus Virus HPV, an infection causes human papillomavirus (HPV). About 90% of HPV...
Siteman Cancer Center has expanded to another facility in Shiloh, Illinois, offering this new geographic location access to advanced clinical research programs for state-of-the-art clinical research as a care option. Because Siteman is a National Cancer...
I-Mab Biopharma dosed its first patient in mainland China as part of its ongoing pivotal Phase II trial evaluating an experimental antibody therapy from Morphosys called MOR202 (TJ202) as a treatment for patients with relapsed or refractory multiple myeloma. This...
An approved drug called pemetrexed is at the center of a new clinical trial being conducted at Providence Saint John Health Center’s Pacific Brain Tumor Center for patients diagnosed with chordoma, a rare, slow-growing cancer found in the bones at the base of the...
A retrospective study driven by Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, found that cancer patients battling viral infections such as HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) shouldn’t be precluded from immune...
